Relife S.r.l.
6
0
0
6
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
0.0%
0 terminated/withdrawn out of 6 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
67%
4 of 6 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (6)
Clinical Investigation on the Efficacy and Safety of Relizema Cream in Paedriatric Patients
Role: lead
Clinical Investigation on the Efficacy and Safety of Relizema Ecofoam
Role: lead
Clinical Investigation on the Performance and Safety of DermoRelizema Ecofoam
Role: lead
Clinical Investigation on the Safety and Clinical Performance of Papix Acne Scar.
Role: lead
Clinical and Instrumental Evaluation on Definisse Threads
Role: lead
Clinical Evaluation of the Safety and Performance of a Filler in Correction of Mid-face Age-related Volume Deficit
Role: lead
All 6 trials loaded